The company's balance sheet is not considered strong due to ...
The company's balance sheet is not considered strong due to its high debt and liabilities, coupled with a decrease in revenue and a loss before interest and tax. The company is considered risky due to these factors.
Hybio Pharmaceutical (SZSE:300199) Is Making Moderate Use Of Debt
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4569Followers
0Following
9985Visitors
Follow